The Centre for Drug Research and Development

The Centre for Drug Research and Development
Brain Research Centre

Brain Research Centre

September 08, 2011 10:30 ET

The Centre for Drug Research and Development and the Brain Research Centre Collaborate to Bring New Therapies to Those Suffering from Neurological Disorders

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 8, 2011) - The Centre for Drug Research and Development (CDRD) and the Brain Research Centre, a partnership between Vancouver Coastal Health Research Institute and the Faculty of Medicine at the University of British Columbia are pleased to announce that they have entered into a Preferred Collaboration Agreement. The two organizations will work together, sharing their resources and expertise to facilitate joint drug development research projects -- focusing on the acceleration of discovery, development and commercialization of technologies for the diagnosis and treatment of neurological and psychiatric disorders.

"Canada is well-recognized worldwide for our neuroscience excellence and our leading research nodes such as the Brain Research Centre," said Karimah Es Sabar, CDRD Senior Vice President, Business and Strategic Affairs. "We are extremely pleased to be working with their team of top researchers to advance the development of their most therapeutically promising discoveries, while further achieving CDRD's mission of translating promising research into viable commercial opportunities for the private sector."

"The diseases that affect the brain represent the largest health challenge in Canada today. By bringing together the Brain Research Centre's talented investigators who are discovering the mechanisms that underlie brain diseases and identifying therapeutic targets, with the drug development capabilities of CDRD, we create tremendous synergies, and facilitate the process by which new therapeutics are brought to the patient," said Max Cynader, Director of the Brain Research Centre.

CDRD and the Brain Research Centre are now working together on a number of research projects. These include a collaboration with Dr. Cheryl Wellington, Associate Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia to screen for novel compounds which increase Apolipoprotein E lipidation in the brain as a therapeutic approach to Alzheimer's disease. A second project is based on the research of Dr. Yu Tian Wang, Professor in the Faculty of Medicine at UBC, who has identified a novel peptide that slows down memory loss and may have therapeutic potential in mild cognitive impairment and early onset Alzheimer's disease.

To these and other projects ongoing in collaboration with the Brain Research Centre, CDRD is providing key scientific and business expertise, state-of-the-art drug development infrastructure, and funding from its three Innovation Funds established with public and private sector strategic partners Genome BC, Pfizer Canada and Johnson & Johnson. This newly formed CDRD/BRC alliance will see further development of these projects, as well as a formalization of the relationship between the two organizations and additional future research collaborations going forward.

About CDRD

The Centre for Drug Research and Development (CDRD), a national Centre of Excellence for Commercialization and Research (CECR), is a not-for-profit public-private organization that provides drug development expertise and infrastructure to enable researchers from leading academic and health research institutions to advance promising, early-stage drug candidates. CDRD has supported some 95 research projects generated from its network of 20+ affiliated research institutions across Canada. These institutions represent billions invested in health-related research every year, and CDRD plays a pivotal role in translating that research into commercial products and economic returns including new jobs for British Columbia and Canada. For additional information, visit

About the Brain Research Centre

The Brain Research Centre comprises 250 investigators with multidisciplinary expertise in neuroscience research ranging from the test tube, to the bedside, to industrial spin-offs. The centre is a partnership of UBC and VCH Research Institute. For more information, visit

Contact Information